期刊文献+

年龄≥60岁的房间隔缺损患者的介入封堵治疗 被引量:2

Transcatheter closure of atrial septal defect in patients over 60 years old
下载PDF
导出
摘要 目的:探讨年龄≥60岁的房间隔缺损(atrial septal defect,ASD)患者介入封堵治疗的安全性和有效性。方法:分析51例拟行ASD介入封堵术的年龄≥60岁患者的临床资料特征及手术效果,并与其他年龄段的成人ASD进行比较。结果:年龄≥60岁的ASD患者(60ASD)占成人ASD的7.9%(51/647例)。60ASD的房颤发生率(27.45%)明显高于18~60岁的ASD患者(59ASD)(3.52%)。60ASD与59ASD患者相比:心脏结构的重构改变更加明显,包括心房和心室增大更多,心腔内压力和肺血管阻力明显增高。但相关性分析显示,ASD患者年龄与肺动脉压力、左房内径、右房内径、左室舒张末内径、右室舒张末内径和肺阻力仅有较弱相关性(r分别为:0.263、0.500、0.215、0.174、0.153、0.335)。60ASD与59ASD患者的手术成功率和主要并发症发生率无差别。不论任何年龄段的患者,术后右心重构均明显改善,表现在右房右室过度充盈减轻,内径缩小;但是60ASD患者心脏重构的改善程度小于59ASD。结果:介入封堵治疗年龄≥60岁的ASD患者安全有效,术后患者心脏重构改善。 Objective:To evaluate the safety and effect of transcatheter closure of atrial septal defect(ASD)in patients aged over 60 years old. Methods:Fifty-one over 60-year-old patients underwent transcatheter ASD closure,and their clinic data and procedural outcome were analyzed in this study. Meanwhile,all the data and outcomes were compared with other age groups. Results:Patients above 60 years old with ASD(60ASD)accounted about 7.9%(51 / 647)of adult ASD patients. The incidence of atrial fibrillation in60ASD(27.45%)was significantly higher than that of ASD patients aged 18~60 years(59ASD)(3.52%). Compared with 59 ASD,the cardiac remodeling showed more obvious effects in 60 ASD. Those effects included atrial and ventricular enlargement,increasing atrioventricular chamber pressure and pulmonary vascular resistance. However, the correlation analysis suggested there was weak correlation between age and pulmonary arterial pressure,left atrial diameter,right atrial diameter,left ventricular end diastolic diameter,right ventricular diastolic diameter,and pulmonary resistance(r =0.263,0.5,0.215,0.174,0.153,0.335,respectively).Successful rates of procedure and major complications didn’t show significant difference between 60 ASD and 59 ASD. Right cardiac remodeling after procedure was significant,as the right atrial / ventricular overload was alleviated and diameter was reduced no matter which age group was the patient in. However,the improvement of 60 ASD cardiac remodeling was less than 59 ASD. Conclusion:Transcatheter ASD closure is effective and safe among ASD patients over 60 years old.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第5期593-596,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(30901473)
关键词 年龄 房间隔缺损 介入封堵 age atrial septal defect transcathter closure
  • 相关文献

参考文献15

  • 1Geva T,Martins JD,Wald RM. Atrial septal defects [J]. Lancet, 2014,383(9932) : 1921-1932.
  • 2Wi J, Choi JY, Shim JM, et al. Fate of preoperative atrial fibrillation after correction of atrial septal defect[J]. Circ J, 2013,77( 1 ) : 109-115.
  • 3Komar M,Przewlocki T,Olszowska M,et al. The benefit of atrial septal defect closure in elderly patients [J]. Clin Interv Aging,2014,9(16) : 1101-1107.
  • 4潘子磊,杨荣,孔祥清,盛燕辉,张浩,孙伟,张海峰,雍永宏,杨悉微,陈明龙,杨兵,张凤祥,居维竹.房间隔缺损并发的心房颤动的治疗探讨[J].南京医科大学学报(自然科学版),2015,35(5):674-677. 被引量:3
  • 5Kim NK,Park SJ, Choi JY. Transcatheter closure of atrial septal defect:does age matter.'? [J]. Korean Circ J,2011,41 (11) :633-638.
  • 6顾正南,杨荣,盛燕辉,孔祥清,张浩,许迪,雍永宏,周蕾,曹克将.动脉导管未闭伴重度肺动脉高压患者的介入治疗[J].南京医科大学学报(自然科学版),2011,31(5):727-729. 被引量:4
  • 7Radke RM,Diller GP,Baumgartner H. The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease[J~. Expert Rev Cardiovase Ther, 2013,11(7) :919-931.
  • 8Altlndag T,Roos-Hesselink JW,Cuypers JA,et al. Tran- scatheter device closure of atrial septal defects in patients aged 40 years and older[J]. Neth Heart J,2010,18( 11): 537-542.
  • 9Khan AA,Tan JL,Li W,et al. The impact of transeatheter a- trial septal defect closure in the older population:a prospective study[J]. JACC Cardiovasc Interv,2010,3 (3) :276-281.
  • 10Woo SB,Jang SI, Kim SH,et al. Transcatheter closure of secundum atrial septal defect in patients over 60 years old[J]. Korean Circ J,2013, 43(2):110-114.

二级参考文献28

  • 1Ji Q, Feng J, Mei Y, et al. Transcatheter closure of adult patent ductus arteriosus with severe pulmonary hypertension [ J]. Hypertens Res, 2008,31 ( 11 ) :1997 - 2002.
  • 2Kalavrouziotis G,Kourtesis A,Paphitis C,et al. Closure of a large patent ductus arteriosus in children and adults with pulmonary hypertension [J]. Hellenic J Cardiol,2010,51 (1) : 15-18.
  • 3Zabal C, Garcia-Montes JA, Buendia-Hemandez A, et al. Percutaneous closure of hypertensive ductus arteriosus[J]. Heart,2010,96(8) :625-629.
  • 4Roy A, Juneja R, Saxena A. Use of Amplatzer duct occludar to closure severely hypertensive duets: utility of transient balloon occlusion [J]. Indian Heart J, 2005,57(4) 1332-336.
  • 5Yan C, Zhao S, Jiang S, et al. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults[J]. Heart,2007,93(4):514- 518.
  • 6Ji Q,Feng J,Mei YQ,et al. Transcatheter closure of adult patent ductus arterious with severe pulmonary hypertension [J]. Hypertens Res,2008,31 (11):1997- 2002.
  • 7Yu ML, Huang XM, Wang JF, et al. Safty and efficacy of transcatheter closure of large patent ductus arterious in adults with a serf-expandable occluder [J]. Heart Vessels, 2009,24(6 ) : 440-445.
  • 8Eerola A, Jokinen E, Boldt T, et al. The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: a prospective study using two-and three-dimensional echoeardiography and nts of serum natriuretic peptides [J]. J Am Coll Cardiol,2006,47(5) : 1060-1066.
  • 9Thanopoulos B, Eleftherakis N, Tzannos K, et al. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder:initial clinical applications in children [J]. Am Heart J,2008,156 (5) :9171-9176.
  • 10Thanopoulos B, Eleftherakis N, Tzannos K, et al. Further experience with catheter closure of patent ductus arteriosus using the new A,nplatzer duct occluder in children [J]. Am J Cardiol, 2010,105 (7): 1005-1009.

共引文献5

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部